Episode Details

Back to Episodes

Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports

Published 2 months ago
Description
Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need …

Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports Read More »

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us